Founded at the Abramson Cancer Center at the University of Pennsylvania
David Porter

David Porter, MD

Director, Cell Therapy and Transplantation and Professor, Medicine

Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Perelman School of Medicine

Dr. Porter is the Jodi Fisher-Horowitz Professor of Leukemia Care Excellence at the Perelman School of Medicine and Abramson Cancer Center, and Director of Cell Therapy and Transplant at the University of Pennsylvania. He graduated from the University of Rochester and earned a medical degree at Brown University. He completed internship and residency at Boston University Hospital, and fellowship training at Brigham and Women’s Hospital and Harvard Medical School.


Dr. Porter chairs or serves on numerous local, national, and international committees focused on hematologic malignancies, stem cell transplantation, and cell therapy. He is Chair of the Board of Directors of the National Marrow Donor Program and serves on cell therapy advisory boards and steering committees for several organizations including the Foundation for the Accreditation of Cell Therapy, Association of American Cancer Institutes, Society for Immunotherapy of Cancer, and Center for International Blood and Marrow Transplant Research. He is the recipient of several prestigious awards at Penn including recognition for Professionalism and Mentorship.


Dr. Porter is an accomplished clinical investigator with research interests in development of novel approaches to cellular therapy and stem cell transplantation. He has worked with colleagues at the University of Pennsylvania to pioneer successful development of CAR T cells (genetically modified T cells) to treat B cell cancers; other research highlights include development of novel trials designed to prevent GVHD after allogeneic SCT by blocking lymphocyte trafficking, and studies to enhance graft-vs-tumor activity at the time of transplant, after non-myeloablative therapy, and for relapse after SCT.

Related Publications